The Valley Desk

ArticleJournal of medical economicsPublished

Cost-effectiveness of perioperative nivolumab + neoadjuvant platinum doublet chemotherapy as treatment for resectable non-small cell lung cancer in the United States

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Journal of medical economics
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Neoadjuvant Therapy; Models, Econometric; Markov Chains; Quality-Adjusted Life Years; Cost-Benefit Analysis; United States; Antineoplastic Agents, Immunological
PubMed ID
40253592
Added to directory
Source checked

Report a correction or request removal